CREW files motion to quash Sanofi Pasteur subpoena

6 December 2012

Washington DC, USA-based non-profit legal watchdog group Citizens for Responsibility and Ethics (CREW) said yesterday that it has filed a motion to quash a subpoena served on it by Sanofi Pasteur, the vaccines unit of French drug major Sanofi (Euronext: SAN) in connection with a law suit doctors have filed against the company alleging anti-competitive practices.

CREW says it has no connection to the law suit, Castro, et al. v Sanofi Pasteur Inc. (D.N.J.), but has asked the Federal Trade Commission to investigate Sanofi and Merck & Co for prohibiting physicians who buy their pediatric vaccines from buying vaccines from other manufacturers or lose price discounts. Because of this practice, doctors can’t offer children the best or most appropriate vaccines, CREW claims.

CREW assertions not accurate, says Sanofi Pasteur

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK